BC
RLAY icon

Boxer Capital’s Relay Therapeutics RLAY Stock Holding History

Boxer Capital’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,819,132
Closed -$12.9M – 45
2024
Q3 		$12.9M Hold
1,819,132
– – 0.63% 40
2024
Q2 		$11.9M Hold
1,819,132
– – 0.62% 40
2024
Q1 		$15.1M Hold
1,819,132
– – 0.75% 37
2023
Q4 		$20M Hold
1,819,132
– – 1% 27
2023
Q3 		$15.3M Hold
1,819,132
– – 0.81% 37
2023
Q2 		$22.8M Sell
1,819,132
-350,000
-16% -$4.35M 1.06% 34
2023
Q1 		$35.7M Hold
2,169,132
– – 1.76% 14
2022
Q4 		$32.4M Hold
2,169,132
– – 1.71% 19
2022
Q3 		$48.5M Sell
2,169,132
-500,000
-19% -$11M 2.73% 10
2022
Q2 		$44.7M Hold
2,669,132
– – 2.83% 10
2022
Q1 		$79.9M Hold
2,669,132
– – 4.11% 6
2021
Q4 		$82M Buy
2,669,132
+1,375,000
+106% +$43.5M 3.18% 9
2021
Q3 		$40.8M Hold
1,294,132
– – 1.42% 21
2021
Q2 		$47.4M Hold
1,294,132
– – 1.67% 13
2021
Q1 		$44.7M Hold
1,294,132
– – 1.52% 19
2020
Q4 		$53.8M Buy
1,294,132
+42,173
+3% +$1.91M 1.73% 15
2020
Q3 		$53.3M Buy
+1,251,959
New +$47.7M 1.84% 13

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Boxer Capital's RLAY Position: Q4 2024 in Review

Boxer Capital sold out of Relay Therapeutics (RLAY) in Q4 2024, closing a stake of 1,819,132 shares — an estimated $12.9M sold.

Boxer Capital first reported a position in RLAY in Q3 2020 and held it in 17 quarters. The position peaked at $82M in Q4 2021. 199 funds tracked by Wall St. Rank hold RLAY as of Q4 2024.

  • Boxer Capital reported no remaining Relay Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Boxer Capital sold 1,819,132 Relay Therapeutics shares in Q4 2024, an estimated $12.9M.
  • Boxer Capital first reported a position in Relay Therapeutics in Q3 2020 and held it in 17 quarters.
  • Boxer Capital's Relay Therapeutics position peaked at $82M in Q4 2021.
  • 199 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2024.

Based on Boxer Capital's 13F filing for Q4 2024.